5-bromo-N-methyl-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl 7-[5-[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-2,7-diazaspiro[4.4]nonane-2-carboxylate;5-(2,7-diazaspiro[4.4]nonan-2-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate

C84H91Br2N27O12 — CID 158022401

About 5-bromo-N-methyl-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl 7-[5-[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-2,7-diazaspiro[4.4]nonane-2-carboxylate;5-(2,7-diazaspiro[4.4]nonan-2-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate

5-bromo-N-methyl-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl 7-[5-[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-2,7-diazaspiro[4.4]nonane-2-carboxylate;5-(2,7-diazaspiro[4.4]nonan-2-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate (PubChem CID 158022401) has the molecular formula C84H91Br2N27O12 and a molecular weight of 1830.64 g/mol. Its IUPAC name is 5-bromo-N-methyl-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl 7-[5-[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-2,7-diazaspiro[4.4]nonane-2-carboxylate;5-(2,7-diazaspiro[4.4]nonan-2-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate.

Molecular Properties

• Compound Name: 5-bromo-N-methyl-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl 7-[5-[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-2,7-diazaspiro[4.4]nonane-2-carboxylate;5-(2,7-diazaspiro[4.4]nonan-2-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate
• PubChem CID: 158022401
• Molecular Formula: C84H91Br2N27O12
• Molecular Weight: 1830.64 g/mol
• Exact Mass: 1827.57
• IUPAC Name: 5-bromo-N-methyl-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl 7-[5-[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-2,7-diazaspiro[4.4]nonane-2-carboxylate;5-(2,7-diazaspiro[4.4]nonan-2-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate
• SMILES: CC(C)(C)OC(=O)N1CCC2(CCN(c3cnc(N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)c(-c4nnc(-c5ccccc5)o4)n3)C2)C1.CNc1ncc(Br)nc1-c1nnc(-c2ccccc2)o1.COC(=O)c1nccnc1N.Nc1ncc(Br)nc1-c1nnc(-c2ccccc2)o1.Nc1ncc(N2CCC3(CCNC3)C2)nc1-c1nnc(-c2ccccc2)o1
• InChI: InChI=1S/C34H45N7O7.C19H21N7O.C13H10BrN5O.C12H8BrN5O.C6H7N3O2/c1-31(2,3)46-28(42)40-18-16-34(21-40)15-17-39(20-34)23-19-35-25(41(29(43)47-32(4,5)6)30(44)48-33(7,8)9)24(36-23)27-38-37-26(45-27)22-13-11-10-12-14-22;20-16-15(18-25-24-17(27-18)13-4-2-1-3-5-13)23-14(10-22-16)26-9-7-19(12-26)6-8-21-11-19;1-15-11-10(17-9(14)7-16-11)13-19-18-12(20-13)8-5-3-2-4-6-8;13-8-6-15-10(14)9(16-8)12-18-17-11(19-12)7-4-2-1-3-5-7;1-11-6(10)4-5(7)9-3-2-8-4/h10-14,19H,15-18,20-21H2,1-9H3;1-5,10,21H,6-9,11-12H2,(H2,20,22);2-7H,1H3,(H,15,16);1-6H,(H2,14,15);2-3H,1H3,(H2,7,9)
• InChIKey: FGFBVKYAIQZKBM-UHFFFAOYSA-N
• XLogP: 14.05
• TPSA: 504.86 Ų
• H-Bond Donors: 5
• H-Bond Acceptors: 37
• Rotatable Bonds: 13
• Heavy Atoms: 125
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	1830.64
LogP ≤ 5	14.05
H-Bond Donors ≤ 5	5
H-Bond Acceptors ≤ 10	37

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 5-bromo-N-methyl-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl 7-[5-[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-2,7-diazaspiro[4.4]nonane-2-carboxylate;5-(2,7-diazaspiro[4.4]nonan-2-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate?

The IUPAC name of 5-bromo-N-methyl-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl 7-[5-[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-2,7-diazaspiro[4.4]nonane-2-carboxylate;5-(2,7-diazaspiro[4.4]nonan-2-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate (CID 158022401) is 5-bromo-N-methyl-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl 7-[5-[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-2,7-diazaspiro[4.4]nonane-2-carboxylate;5-(2,7-diazaspiro[4.4]nonan-2-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate.

What is the SMILES notation for 5-bromo-N-methyl-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl 7-[5-[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-2,7-diazaspiro[4.4]nonane-2-carboxylate;5-(2,7-diazaspiro[4.4]nonan-2-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate?

The canonical SMILES for 5-bromo-N-methyl-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl 7-[5-[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-2,7-diazaspiro[4.4]nonane-2-carboxylate;5-(2,7-diazaspiro[4.4]nonan-2-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate is CC(C)(C)OC(=O)N1CCC2(CCN(c3cnc(N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)c(-c4nnc(-c5ccccc5)o4)n3)C2)C1.CNc1ncc(Br)nc1-c1nnc(-c2ccccc2)o1.COC(=O)c1nccnc1N.Nc1ncc(Br)nc1-c1nnc(-c2ccccc2)o1.Nc1ncc(N2CCC3(CCNC3)C2)nc1-c1nnc(-c2ccccc2)o1.

What is the InChIKey of 5-bromo-N-methyl-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl 7-[5-[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-2,7-diazaspiro[4.4]nonane-2-carboxylate;5-(2,7-diazaspiro[4.4]nonan-2-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate?

The InChIKey is FGFBVKYAIQZKBM-UHFFFAOYSA-N. The full InChI is InChI=1S/C34H45N7O7.C19H21N7O.C13H10BrN5O.C12H8BrN5O.C6H7N3O2/c1-31(2,3)46-28(42)40-18-16-34(21-40)15-17-39(20-34)23-19-35-25(41(29(43)47-32(4,5)6)30(44)48-33(7,8)9)24(36-23)27-38-37-26(45-27)22-13-11-10-12-14-22;20-16-15(18-25-24-17(27-18)13-4-2-1-3-5-13)23-14(10-22-16)26-9-7-19(12-26)6-8-21-11-19;1-15-11-10(17-9(14)7-16-11)13-19-18-12(20-13)8-5-3-2-4-6-8;13-8-6-15-10(14)9(16-8)12-18-17-11(19-12)7-4-2-1-3-5-7;1-11-6(10)4-5(7)9-3-2-8-4/h10-14,19H,15-18,20-21H2,1-9H3;1-5,10,21H,6-9,11-12H2,(H2,20,22);2-7H,1H3,(H,15,16);1-6H,(H2,14,15);2-3H,1H3,(H2,7,9).

What are the key properties of 5-bromo-N-methyl-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl 7-[5-[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-2,7-diazaspiro[4.4]nonane-2-carboxylate;5-(2,7-diazaspiro[4.4]nonan-2-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate?

5-bromo-N-methyl-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl 7-[5-[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-2,7-diazaspiro[4.4]nonane-2-carboxylate;5-(2,7-diazaspiro[4.4]nonan-2-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate has a molecular weight of 1830.64 g/mol, XLogP of 14.05, 13 rotatable bonds, 5 hydrogen bond donors, and 37 hydrogen bond acceptors.

Where does this data come from?

All data for 5-bromo-N-methyl-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;tert-butyl 7-[5-[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]-6-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-2,7-diazaspiro[4.4]nonane-2-carboxylate;5-(2,7-diazaspiro[4.4]nonan-2-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-amine;methyl 3-aminopyrazine-2-carboxylate is sourced from PubChem (CID 158022401), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).